Our findings suggest that GLP1s may have beneficial effects on asthma control for people with obesity and this should be explored further. Professor Alan Kaplan, Chairperson of the Family Physician Airways Group of Canada and the Observational and Pragmatic Research Institute, added: "Our findings suggest that GLP1-RAs have benefits on asthma control in people with obesity, and this information should contribute to the discussions around the decision to use these drugs."
GLP-1 drugs for weight loss are self-injecting medicines
doi:10.1016/j.numecd.2019.10.002 Asbaghi O, Sadeghian M, Nasiri M, et al
A healthcare provider must evaluate your medical history, current medications, and weight loss goals before prescribing it
After the drugs were administered to the test subjects for 3 months they underwent the Morris water maze test
What are the best electrolytes for Ozempic users